March 21, 2014:

Rutgers University President Dr. Robert Barchi recently cited the Big Ten Cancer Research Consortium as an example of the academic collaboration that is possible between the Big Ten member institutions.

“This consortium of world-class academic institutions will enable a collaborative approach to improving our understanding of cancer in the lab and our treatment of cancer in our hospitals,” Barchi said in a letter to the Rutgers community.

Read Dr. Barchi’s letter.

The Rutgers Cancer Institute of New Jersey is one of 12 member institutions in the Big Ten Cancer Research Consortium.

About the Big Ten Cancer Research Consortium: The Big Ten Cancer Research Consortium creates a unique team-research culture to drive science rapidly from ideas to treatment-changing paradigms. Within this innovative environment, today’s research leaders collaborate with and mentor the research leaders of tomorrow with the unified goal of improving the lives of all patients with cancer.

About the Big Ten Conference: The Big Ten Conference is an association of world-class universities whose member institutions share a common mission of research, graduate, professional and undergraduate teaching and public service. Founded in 1896, the Big Ten has sustained a comprehensive set of shared practices and policies that enforce the priority of academics in student-athletes’ lives and emphasize the values of integrity, fairness and competitiveness. The broad-based athletic programs of the 12 Big Ten institutions provide in excess of $141 million in direct financial aid to more than 8,200 student-athletes playing on more than 300 teams in 43 different sports. The Big Ten sponsors 26 official conference sports, 13 for men and 13 for women, and will add men’s and women’s lacrosse as the 27th and 28th official sports for the 2014-15 academic year. For more information, visit